Literature DB >> 28166282

Correction: Natural and Undetermined Sudden Death: Value of Post-Mortem Genetic Investigation.

Olallo Sanchez, Oscar Campuzano, Anna Fernández-Falgueras, Georgia Sarquella-Brugada, Sergi Cesar, Irene Mademont, Jesus Mates, Alexandra Pérez-Serra, Monica Coll, Ferran Pico, Anna Iglesias, Coloma Tirón, Catarina Allegue, Esther Carro, María Ángeles Gallego, Carles Ferrer-Costa, Anna Hospital, Narcís Bardalet, Juan Carlos Borondo, Albert Vingut, Elena Arbelo, Josep Brugada, Josep Castellà, Jordi Medallo, Ramon Brugada.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0167358.].

Entities:  

Year:  2017        PMID: 28166282      PMCID: PMC5293246          DOI: 10.1371/journal.pone.0171893

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There is information missing from the Funding statement. The complete funding information is as follows: This work was supported by Obra Social "La Caixa", Fondo Investigacion Sanitaria -FIS PI14/01773- from the Instituto de Salud Carlos III (ISCIII), and Fundació Academia de Ciències Mèdiques i de la Salut de Catalunya i de Balears (ACMCB-2013). The commercial founder Gendiag S.L provided support in the form of salaries for authors CF and RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.
  1 in total

1.  Natural and Undetermined Sudden Death: Value of Post-Mortem Genetic Investigation.

Authors:  Olallo Sanchez; Oscar Campuzano; Anna Fernández-Falgueras; Georgia Sarquella-Brugada; Sergi Cesar; Irene Mademont; Jesus Mates; Alexandra Pérez-Serra; Monica Coll; Ferran Pico; Anna Iglesias; Coloma Tirón; Catarina Allegue; Esther Carro; María Ángeles Gallego; Carles Ferrer-Costa; Anna Hospital; Narcís Bardalet; Juan Carlos Borondo; Albert Vingut; Elena Arbelo; Josep Brugada; Josep Castellà; Jordi Medallo; Ramon Brugada
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.